ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
European Commission grants marketing authorisation for Vumerity®
November 18, 2021Biogen has announced that the European Commission (EC) has granted marketing authorisation for Vumerity® (diroximel fumarate) to treat adults with relapsing-remitting multiple sclerosis (MS). -
Alkermes/Biogen hope for less tummy trouble with new MS pill
December 19, 2018Alkermes and Biogen have filed a new multiple sclerosis pill with the FDA, which they hope will treat the disease with fewer unpleasant gastrointestinal side effects than the big pharma’s older MS drug, Tecfidera.
Pharma Sources Insight January 2025
